Krystal Eckhart
On May 15, 2026, the Board of Directors of the Company appointed Krystal Eckhart to serve as the Company’s Interim CEO and CFO.
Highest-materiality recent filing
CEO/CFO Adam Desmond resigns; Krystal Eckhart appointed interim CEO and CFO
Adam Desmond resigned as CEO, CFO, and board member effective May 14, 2026.
Selectis Health sells two Georgia SNFs for $15.7M; net proceeds ~$9M
Sold Glen Eagle Healthcare (101-bed, Abbeville) and Eastman Healthcare (100-bed) to GA SNF entities.
Selectis Health board member David Furstenberg resigns effective March 30, 2026
David Furstenberg resigned from the Board of Directors and Audit Committee on March 30, 2026.
Selectis Health appoints Richard Huebner to Board of Directors effective March 12, 2026
Richard Huebner, age 68, appointed to Selectis Health Board effective March 12, 2026.
Selectis Health agrees to sell two Georgia skilled nursing facilities for $15.7M
Purchase price $15.7M for Glen Eagle (101-bed) and Eastman (100-bed) facilities in Georgia.
Selectis Health sells two Georgia skilled nursing facilities for $13.175 million
Sold Sparta (71-bed) and Warrenton (110-bed) facilities for aggregate $13.175M; escrow of $1.3M.
Selectis Health appoints Kent Lund and Lance Baller to Board of Directors
Effective January 1, 2026, Board appointed Kent Lund, age 70, with legal/securities background and former FINRA committee member.
Selectis Health extends $1.775M notes to Feb 2026, interest rate raised to 13%
Maturity extended to Feb 28, 2026 or earlier upon Qualified Transaction; 30-day extensions possible with 0.5% fee.
Selectis Health agrees to sell two Georgia skilled nursing facilities for $13.175M
Total purchase price $13,175,000 for 71-bed Sparta and 110-bed Warrenton facilities.
Purchaser terminated the Purchase and Sale Agreement and Operations Transfer Agreement for Georgia subsidiaries effective July 13, 2025.
Selectis Health's common stock approved for OTCQB quotation effective June 23
Received OTC Markets approval for upgraded quotation on the OTCQB tier.
On May 15, 2026, the Board of Directors of the Company appointed Krystal Eckhart to serve as the Company’s Interim CEO and CFO.
Effective May 14, 2026 the Board of Directors of Selectis Health, Inc., a Utah corporation (the “Company”) and Adam Desmond (“Desmond”) agreed that he would resign all positions with the Company including CEO, CFO of the Company and a member of the Board of Directors.
Max materiality 0.75 · Median 0.65 · Most common event leadership